Chloe Kim

Artificial intelligence is rapidly becoming one of the most heavily promoted technologies in healthcare diagnostics. AI-powered biosensors, automated interpretation systems, and machine-learning-assisted point-of-care platforms are now appearing across hospitals, startups, and decentralized healthcare models worldwide. However, behind the growing excitement, many diagnostics experts argue the industry still faces a quieter problem that AI alone cannot solve: unstable measurement systems and unreliable real-world data.

The conversation around AI infrastructure often focuses on access. More GPUs, more capacity, and more compute are commonly viewed as the path to greater AI competitiveness.

Korea proved during the COVID-19 pandemic that it could rapidly develop and export diagnostic products at global scale.

For years, the biggest challenge in artificial intelligence was gaining access to powerful models. Today, that barrier is steadily falling.

A user downloads an app, creates an account, and explores the service. The product works, the interface feels polished, and the pricing is competitive. Yet the transaction never happens. In South Korea, that hesitation is often not a product problem. Because for most new startups, it is more of a trust problem. Increasingly, Korean consumers are making decisions through a digital trust layer built on familiar platforms, payment systems, and validation channels long before they decide to buy.

Korea's content industry has spent years building world-class intellectual property (IP) through webtoons, web novels, books, and original storytelling.

A beauty app recommends a product. An AI search engine summarizes the answer. A healthcare platform flags a potential risk.

For years, discussions around Korea's content industry focused on creating the next hit drama, expanding global distribution, or investing in larger

\Korea is opening more pathways for foreign founders, but household readiness, approvals, and administrative systems still shape post-arrival success today.

A Series A investor had already put a term sheet on the table. The startup had a strong product, credible traction, and public recognition.